Citing ‘unwarranted opposition’ to its transition, PMI sold the firm for about a third of the purchase price.Read More
Tags :Vectura
'Unwarranted opposition' to PMI’s transformation has negatively impacted the pharmaceutical company’s business, according to the multinational. Read More
